Ninad S Chaudhary1, Michael A Grandner2, Nicholas J Jackson3, Subhajit Chakravorty4. 1. Department of Emergency Medicine, UAB School of Medicine, Birmingham, AL; Department of Epidemiology, UAB School of Public Health, Birmingham, AL. Electronic address: Drninadsc@gmail.com. 2. University of Arizona College of Medicine, Tucson, AZ. 3. University of Southern California, Los Angeles, CA. 4. Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA; Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA.
Abstract
OBJECTIVE: Insomnia symptoms have been individually associated with both caffeine consumption and sleep duration abnormalities in prior studies. The goal of this study was to determine whether caffeine consumption was associated with insomnia symptoms from a population perspective and whether this relationship depended on habitual sleep duration. METHODS: Data were extracted from the 2007-2008 National Health and Nutritional Examination Survey (N = 4730). Caffeine consumption was quantified as mg/d from 2 typical days of use, 7 to 10 d apart. Insomnia symptoms were evaluated using frequencies of difficulty falling asleep (DFA), difficulty staying asleep (DSA), non-restorative sleep (NRS), and daytime sleepiness (DS). Habitual sleep duration was assessed as the hours of sleep obtained on a typical night. Binomial logistic regression analysis evaluated the relationships of individual insomnia and sleepiness symptoms (DFA, DSA, NRS, and DS) with caffeine consumption and sleep duration variables, after adjusting for covariates. RESULTS: The mean ± SD caffeine consumption was 176.6 ± 201 mg/d. Mean habitual sleep duration was 6.8 ± 1.4 h. Insomnia symptoms were prevalent in 19.1% to 28.4% of the respondents. Although caffeine consumption was associated with all insomnia symptoms in the unadjusted models, the adjusted models demonstrated a trend toward significance with DSA. Sleep duration was inversely associated with the insomnia symptoms in unadjusted and adjusted analysis. Finally, NRS was associated with an interaction between increased caffeine consumption and sleep duration. CONCLUSION: The association between caffeine use and insomnia symptoms depends on habitual sleep duration at a population level.
OBJECTIVE:Insomnia symptoms have been individually associated with both caffeine consumption and sleep duration abnormalities in prior studies. The goal of this study was to determine whether caffeine consumption was associated with insomnia symptoms from a population perspective and whether this relationship depended on habitual sleep duration. METHODS: Data were extracted from the 2007-2008 National Health and Nutritional Examination Survey (N = 4730). Caffeine consumption was quantified as mg/d from 2 typical days of use, 7 to 10 d apart. Insomnia symptoms were evaluated using frequencies of difficulty falling asleep (DFA), difficulty staying asleep (DSA), non-restorative sleep (NRS), and daytime sleepiness (DS). Habitual sleep duration was assessed as the hours of sleep obtained on a typical night. Binomial logistic regression analysis evaluated the relationships of individual insomnia and sleepiness symptoms (DFA, DSA, NRS, and DS) with caffeine consumption and sleep duration variables, after adjusting for covariates. RESULTS: The mean ± SD caffeine consumption was 176.6 ± 201 mg/d. Mean habitual sleep duration was 6.8 ± 1.4 h. Insomnia symptoms were prevalent in 19.1% to 28.4% of the respondents. Although caffeine consumption was associated with all insomnia symptoms in the unadjusted models, the adjusted models demonstrated a trend toward significance with DSA. Sleep duration was inversely associated with the insomnia symptoms in unadjusted and adjusted analysis. Finally, NRS was associated with an interaction between increased caffeine consumption and sleep duration. CONCLUSION: The association between caffeine use and insomnia symptoms depends on habitual sleep duration at a population level.
Authors: Michael A Grandner; Nirav P Patel; Philip R Gehrman; Michael L Perlis; Allan I Pack Journal: Sleep Med Rev Date: 2009-11-06 Impact factor: 11.609
Authors: Tom M McLellan; Gary H Kamimori; Douglas G Bell; Ingrid F Smith; Dagny Johnson; Gregory Belenky Journal: Aviat Space Environ Med Date: 2005-01
Authors: Montserrat Sanchez-Ortuno; Nicholas Moore; Jacques Taillard; Cédric Valtat; Damien Leger; Bernard Bioulac; Pierre Philip Journal: Sleep Med Date: 2005-01-24 Impact factor: 3.492
Authors: Brenda M Malinauskas; Victor G Aeby; Reginald F Overton; Tracy Carpenter-Aeby; Kimberly Barber-Heidal Journal: Nutr J Date: 2007-10-31 Impact factor: 3.271
Authors: Joy Sun; Miranda V McPhillips; Ker-Cheng Chen; Yinyin Zang; Junxin Li; Jessica Oehlke; Glenna S Brewster; Nalaka S Gooneratne Journal: J Clin Sleep Med Date: 2021-05-01 Impact factor: 4.062
Authors: Ninad S Chaudhary; Brittany V Taylor; Michael A Grandner; Wendy M Troxel; Subhajit Chakravorty Journal: Pharmacol Biochem Behav Date: 2021-05-15 Impact factor: 3.697
Authors: Sha Li; Daniel Yee Tak Fong; Janet Yuen Ha Wong; Bradley McPherson; Esther Yuet Ying Lau; Lixi Huang; Mary Sau Man Ip Journal: BMC Public Health Date: 2021-04-01 Impact factor: 3.295
Authors: Reem Al Marshad; Razan Al Khatib; Hanine Amer; Munirah Al Shammari; Aysha Al Otaibi; Fahad Al Otaibi; Nadiah Behbehani; Anwaar Al Sayed; Norah Al Hoty; Zuheir Hassan; Amer Kamal Journal: Int J Health Sci (Qassim) Date: 2018 May-Jun